Le Lézard
Classified in: Health
Subject: PLW

First Patent Filed To Regrow Hair With Human Cells By DNA Hair Regeneration


CLEARWATER, Fla., Jan. 3, 2018 /PRNewswire/ -- John Satino Research Coordinator, at Hair & Scalp Clinics in Clearwater Fl., confirmed their application of a US Provisional Patent, to extract Growth Factors and Circulating Stem Cells from Human Blood, for Hair Re-growth. This has been combined with Aphanizomenon  to mobilize CD34+CD133 Stem Cells. The Process involves injecting hair roots on balding scalps, one at a time. Satino stated they have injected over two hundred individuals to date, with one hundred percent success. The company has posted the technical information along with several before and after photos on the web site WWW.DNAhairRegeneration.com.

 

Media Contact: John Santino, 800-883-4247, [email protected]

SOURCE DNA Hair Regeneration


These press releases may also interest you

at 22:03
Health & Wellness Food Market Projected to Reach $859.43 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas' XTANDItm (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Astellas Pharma Inc....

at 19:15
New Study in Colorado Reveals Alarming Rates of Colorado Teens Missing School
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plustm, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

More news about Health...


News published on and distributed by: